Inactive Instrument

Insiders CytRx Corporation Nasdaq

Equities

US2328286081

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

CytRx Corporation Appoints Cary J. Claiborne to its Board of Directors and as Member of Audit Committee and Chairperson of Compensation Committee	22-08-09	CI
CytRx Corporation Announces Director Changes	22-06-02	CI
CytRx Corporation Announces Board Retirements	22-03-09	CI
Cytrx Corporation Announces Changes to its Board	22-01-03	CI
CytRx Corporation Announces Executive Changes, Effective January 10, 2022	22-01-03	CI
CytRx Corporation Announces Board Changes	21-07-29	CI
Earl Brien Resigns as Director of CytRx Corporation	21-05-27	CI
CytRx Corporation Announces Management Changes	20-03-10	CI
CytRx Corporation Approves Appointment of Eric L. Curtis to the Executive Management Team, as President and Chief Operating Officer, Effective May 3, 2018	18-05-03	CI
Cytrx Corporation Announces Key Addition to Corporate Development Team	18-03-01	CI
CytRx Corporation Announces Management Changes	17-06-13	CI
CytRx Corporation Announces Board Changes	17-05-11	CI
CytRx Corporation Appoints Daniel Levitt as Chief Operating Officer	16-12-19	CI
CytRx Corporation Appoints Earl Warren Brien to its Board of Directors	16-12-02	CI
Cheryl Cohen Resigns as a Director of CytRx Corporation	16-10-19	CI
Benjamin S. Levin, Former Senior Vice President and General Counsel, Retires from CytRx Corporation as of May 31, 2016	16-06-01	CI
CytRx Corporation Hires Olivia Ware as its Chief Commercial Officer and Member of Senior Executive Team	16-01-11	CI
CytRx Corporation Nominates Next Clinical Drug Candidate DK049	15-12-07	CI
CytRx Corporation Appoints Cheryl Cohen to its Board of Directors	15-06-24	CI
CytRx Corporation Announces Board Changes	15-05-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders CytRx Corporation Nasdaq

Equities

US2328286081

Insiders

Filters